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The myelin sheath surrounding axons ensures that nerve impulses travel quickly and efficiently, allowing for the proper function of the
vertebrate nervous system.We previously showed that the adhesion G-protein-coupled receptor (aGPCR) Gpr126 is essential for periph-
eral nervous systemmyelination, although the molecular mechanisms by which Gpr126 functions were incompletely understood. aGP-
CRs are a significantly understudied protein class, and it was unknown whether Gpr126 couples to G-proteins. Here, we analyze DhhCre;
Gpr126fl/fl conditional mutants, and show that Gpr126 functions in Schwann cells (SCs) for radial sorting of axons and myelination.
Furthermore, we demonstrate that elevation of cAMP levels or protein kinase A activation suppresses myelin defects in Gpr126mouse
mutants and that cAMP levels are reduced in conditional Gpr126 mutant peripheral nerve. Finally, we show that GPR126 directly
increases cAMP by coupling to heterotrimeric G-proteins. Together, these data support a model in which Gpr126 functions in SCs for
proper development and myelination and provide evidence that these functions are mediated via G-protein-signaling pathways.
Introduction
Myelin is essential for the proper function of the vertebrate ner-
vous system. During peripheral nervous system (PNS) develop-
ment, immature Schwann cells (SCs) are associated with many
axons; in a process called radial sorting, immature SCs insert
cytoplasmic projections into axon bundles to separate individual
axons. Some immature SCs develop into nonmyelinating Remak
SCs that ensheath multiple small caliber axons. Other immature
SCs become promyelinating SCs that are associated in a 1:1 rela-
tionshipwith a single axonal segment.Myelinating SCs iteratively
wrap their membrane around their associated axonal segment to
generate the myelin sheath (Jessen and Mirsky, 2005).
We previously showed that the adhesion G-protein-coupled
receptor (aGPCR) Gpr126 is essential for PNS myelination. aG-
PCRs represent a unique protein class defined structurally by a
seven-transmembrane helix region (7TM) and an extremely large
extracellular N terminus, separated from the 7TM by a GPCR
autoproteolysis-inducing (GAIN) domain and a GPCR proteo-
lytic site (GPS) domain. These domains split the receptor during
the maturation process into N-terminal and C-terminal frag-
ments that are thought to remain noncovalently attached at the
cell surface (Arac¸ et al., 2012). The extracellular regions of many
aGPCRs contain domains that are involved in cell–cell or cell–
matrix adhesion in other proteins (Yona et al., 2008). The 7TM is
classically defined by its ability to bind heterotrimeric G-proteins
within a cell, through which signal transduction cascades are ac-
tivated upon agonist binding. For example, the G-protein sub-
unit Gs activates adenylyl cyclases to elevate cAMP levels,
whereas Gi inhibits adenylyl cyclases to decrease cAMP levels
(Gilman, 1984). Via release of G dimers, Gi-proteins mediate
diverse additional functions, including modulation of phospha-
tidylinositol 3-kinase (PI3K; Lin and Smrcka, 2011). The major-
ity of aGPCRs remain undercharacterized, and for most family
members, the biological functions, activating ligands, and down-
stream effectors are unknown.
Our previous work defined the first known function of
Gpr126 as an essential regulator of PNSmyelination. In germline
zebrafish andmouseGpr126mutants, SCs fail tomyelinate axons
(Monk et al., 2009, 2011). Analysis of genetic chimeras in
zebrafish suggested that Gpr126 is required in SCs for myelin
protein expression (Monk et al., 2009). However, mouse
Gpr126/mutant peripheral nerves have many defects not ob-
served in zebrafish mutants, including radial sorting delays, limb
contracture defects, and axon degeneration (Monk et al., 2011),
raising questions regarding the cellular autonomy of Gpr126 in
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mammals. Furthermore, germline deletion of Gpr126 is lethal in
mouse, precluding analysis beyond early postnatal stages. Here,
we analyze Gpr126 conditional mutant mice, and our data suggest
that Gpr126 functions in SCs for timely radial sorting andmyelina-
tion.Wealso show that elevating cAMP levels and activatingprotein
kinaseA(PKA) restoresmyelination inGpr126/myelinating cul-
tures, that cAMP is downregulated in Gpr126 conditional mutant
nerves, and that GPR126 couples to the Gs-protein and Gi-protein
families. These data demonstrate that Gpr126 is required autono-
mously inSCs forproperdevelopmentandstrongly supportamodel
inwhichGpr126, via interactionswithG-proteins,modulates cAMP
levels in SCs to control differentiation andmyelination.
Materials andMethods
Mice.All animal experiments were performed in compliance withWash-
ington University’s institutional animal protocols.Gpr126/ constitu-
tive knock-out mouse generation and genotyping have been described
previously (Monk et al., 2011). Conditional Gpr126 mutant mice
(Gpr126fl/fl mice) were generated by Lexicon Pharmaceuticals, and
Gpr126fl/ mice were obtained from Taconic (catalog number TF0269)
on amixed background (129SvEvBrd).We used the following primers to
detect the presence of the floxed allele: 5–CATTGAGCTCTCCCTG-
TATGG–3; 5–CCTGCAGGTACCCACACATG–3. Gpr126fl/fl mice
were crossed to ActinCre mice on a pure C57BL/6 background (Lewan-
doski et al., 1997), and ActinCre;Gpr126fl/ mice were crossed to
Gpr126fl/fl mice to generate ActinCre;Gpr126fl/fl mice and their sibling
controls. ActinCre mice were genotyped as described previously (Ab-
dulkadir et al., 2002).Gpr126fl/flmicewere also crossed toDhhCremice on
a pure C57BL/6 background (Jaegle et al., 2003), and DhhCre;Gpr126fl/
mice were crossed to Gpr126fl/fl mice to generate DhhCre;Gpr126fl/fl mice
and their sibling controls.DhhCremice were genotyped as described pre-
viously (Jaegle et al., 2003). To assess recombination of the floxed allele,
we used the ROSA26 LacZ reporter strain (Soriano, 1999). For all mouse
experiments, mice of either sex were analyzed, and mutants were always
compared with littermate sibling controls.
RT-PCR. Standard RT-PCR was performed as described previously
(Monk et al., 2011) on cDNA derived from ActinCre;Gpr126fl/fl and
sibling control postnatal day (P) 1 lung tissue or on cDNA derived from
DhhCre;Gpr126fl/fl and sibling control P14 lung or sciatic nerve tissue. For
sciatic nerve, we pooled four nerves from two Gpr126fl/ mice and six
nerves from three DhhCre;Gpr126fl/fl mice (all mice were siblings).
In situ hybridization.Mice were intracardially perfused with 4% PFA.
Tissues were dissected and postfixed in the same fixative at 4°C over-
night. After protecting in 30% sucrose and embedding in optimal cutting
temperature compound, frozen sections were prepared at 7 m on a
cryostat (Leica). In situ hybridization was performed as previously de-
scribed (VanDunk et al., 2011) on sections from DhhCre;Gpr126fl/fl (n
2) and sibling control (n  2 DhhCre;Gpr126fl/ siblings) P21 sciatic
nerve and dorsal root ganglia (DRGs). Antisense and sense control
digoxigenen-labeled riboprobes were transcribed as described previously
(Patra et al., 2013).
Immunohistochemistry. For tissue sections, mice were processed as de-
scribed for in situ hybridization. Antibody staining was performed as
described previously (Jeong et al., 2012). For myelinating DRG cultures,
cells were fixed at room temperature with 4% PFA in PBS for 30 min.
After washing with PBS, cells were permeabilized with ice-coldmethanol
and plates were kept at20°C for 20 min. Cells were washed again with
PBS and blocked with PBS containing 2%BSA plus 10% goat serum plus
0.1% Triton X-100 for 30 min at room temperature. Primary antibodies
were suspended in the blocking buffer and cells were incubated for 1 h at
room temperature. Cells were washed with PBS and incubated with ap-
propriate fluorescently labeled secondary antibodies (1:1000; Invitro-
gen) in blocking buffer for 1 h at room temperature. After washing with
PBS, coverslips were mounted on glass slides using Vectashield with
DAPI (Vector Labs). We used the following primary antibodies: rat anti-
MBP (1:10; AbD Serotec), rabbit anti-s100 (1:400; Dako), rabbit-anti-
TUJ1 (1:1000; Covance), chicken anti--galactosidase (1:200; Abcam).
Transmission electron microscopy. Mice were intracardially perfused
with modified Karnovsky’s fix (2% glutaraldehyde plus 4% PFA in 0.1 M
sodium cacodylate, pH 7.4), and sciatic nerves were removed and post-
fixed in the same fixative at 4°C overnight. Nerves were postfixed and
embedded as described previously (Monk et al., 2011). Semithin sections
(200 nm) were stained with toluidine blue, viewed on a light microscope
(Zeiss AxioImager M2), and images were recorded with an AxioCam
MRm. Thin sections (70 nm) were stained with uranyl acetate and Sato’s
lead stain, and then viewed on a Jeol (JEM-1400) electron microscope.
Images were recorded with an Advanced Microscopy Techniques V601
digital camera. We examined three siblings (one Gpr126fl/, one
Gpr126fl/fl, and one DhhCre;Gpr126fl/) and four DhhCre;Gpr126fl/fl mu-
tants at P1; four siblings (twoGpr126fl/fl and twoDhhCre;Gpr126fl/) and
three DhhCre;Gpr126fl/fl mutants at P10; four siblings (four DhhCre;
Gpr126fl/) and three DhhCre;Gpr126fl/fl mutants at P21; three siblings
(two Gpr126fl/fl and one DhhCre;Gpr126fl/) and three DhhCre;Gpr126fl/fl
mutants at P42. For quantifications, we quantified all visible axons and
their relationships with SCs at 3000 magnification from four to five
randomly selected areas of two DhhCre;Gpr126fl/fl mutant and three sib-
ling (DhhCre;Gpr126fl/) controls.
Proliferation assay and nuclei quantification. To quantify proliferation,
sciatic nerve cryosections were obtained and processed as described for
immunocytochemistry. Rabbit anti-Ki67 (1:200; Abcam) and appropri-
ate secondary antibody (1:1000; Invitrogen) were used to identify prolif-
erating cells. The total number of nuclei (DAPI) and the total number
of proliferating cells (Ki67) cells per sciatic nerve were counted manu-
ally for four control (DhhCre;Gpr126fl/) and fourDhhCre;Gpr126fl/flmu-
tants at P4. To quantify total nuclei, we counted the total number of
nuclei from semithin sections obtained from the same P21 animals de-
scribed for transmission electron microscopy (TEM). SC nuclei were
identified based on morphology (see Fig. 3D) and were confirmed by
electron microscopy to be associated with axons and in possession of a
basal lamina (see Fig. 5F ).
Myelinating DRG cultures.Myelinating DRG cultures were performed
according to standard methods (Eldridge et al., 1987) with minor mod-
ifications. Briefly, DRGs were removed from embryonic day (E) 12.5
mouse embryos and plated on Matrigel (BD Biosciences)-coated cover-
slips. Embryos were genotyped as described previously (Monk et al.,
2011). DRGs were cultured in neurobasal media containing 2% B27
(Invitrogen) and 50 ng/mlNGF (Harlan Labs).Media was changed every
other day for the duration of culture. After 7–8 d in vitro, SCs were
confluent along axons and 50 g/ml ascorbic acid (Sigma-Aldrich) was
added to induce the formation of basal lamina.We added 5M forskolin
(Sigma-Aldrich) or 250 M 8-CTP-cAMP (BioLog) to experimental
wells at the same time as ascorbic acid. These conditionsweremaintained
for 3 weeks, at which point the cultures were fixed and subjected to
immunohistochemistry. Three independent experiments were per-
formed in triplicate.
In vivo cAMP measurement. cAMP concentration in the sciatic nerves
wasmeasured using cAMPmeasurement kit (Enzo Life Sciences) according
to the manufacturer’s instructions. Briefly, sciatic nerves from DhhCre;
Gpr126fl/flmice (n 3) and control animals (n 5Gpr126fl/flmice) were
homogenized in ice-cold trichloroacetic acid. After centrifugation, the
supernatant was clarified of cell debris by water-saturated ether, the clar-
ified supernatant was lyophilized overnight, and the dried pellet was
resuspended in manufacturer-provided buffer. cAMP levels were mea-
sured in this suspension, and cAMP concentrations were quantified us-
ingAssay Blaster software (Enzo Life Sciences). Control valueswere set to
100%, andmutant cAMP concentrations were calculated as a percentage
of control.
In vitro functional assays. Full-length human (NM001032395.2)
GPR126 sequence was directly cloned from human monocyte cDNA
library (primers: forward, ATGATGTTTCGCTCAGATCGAATG, and
reverse, TTAAAACTTTGTGCTGTGGCTG) and inserted into the
mammalian expression vector pcDps. The human GPR126 cDNA was
N-terminally tagged after the initial signal peptide at amino acid position
38 with a hemagglutinin (HA) epitope and C-terminally tagged with a
FLAG epitope by a PCR-based site-directed mutagenesis and fragment
replacement strategy.
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COS-7 cells were grown in DMEM supple-
mentedwith 10% fetal bovine serum, 100U/ml
penicillin, and 100g/ml streptomycin at 37°C
and 7%CO2 in a humidified atmosphere. Cells
were split into 12-well plates [1  105 cells/
well, for inositol phosphate (IP3) assay] and
48-well plates (3  104 cells/well for cAMP
assay) and transfected with Lipofectamine
2000 (Invitrogen) according to the manufac-
turer’s protocol. To measure IP3 formation,
transfected COS-7 cells were incubated with 2
Ci/ml myo-[ 3H]inositol (18.6 Ci/mmol;
PerkinElmer Life Sciences) for 16 h. Thereaf-
ter, cells were washed once with serum-free
DMEM containing 10 mM LiCl followed by in-
cubation with serum-free DMEM containing
10 mM LiCl for 1 h at 37°C. Intracellular IP3
levels were determined by anion-exchange
chromatography as described previously (Ber-
ridge, 1983). IP3 accumulation data were ana-
lyzed using GraphPad Prism version 5.0 for
Windows (GraphPad Software). For cAMP
measurements, 48 h after transfection, cells
were incubated with 3-isobutyl-methyl-
xanthine (1 mM)-containing medium for 1 h.
Incubation was stopped by washing with ice-
cold PBS. Cells were lysed in LI buffer
(PerkinElmer Life Sciences) and frozen at
20°C until measurement. To measure cAMP
concentration, the AlphaScreen cAMP assay
kit (PerkinElmer Life Sciences) was used ac-
cording to the manufacturer’s protocol. The
accumulated cAMP was measured in 384-
well white OptiPlate microplates (PerkinEl-
mer Life Sciences) with the Fusion
AlphaScreen multilabel reader (PerkinElmer
Life Sciences). To estimate cell surface expres-
sion of receptors carrying an N-terminal HA
tag, we used an indirect cellular ELISA as de-
scribed previously (Scho¨neberg et al., 1998).
Statistical analysis. For TEM quantification,
we performed a two-tailed Student’s t test. For
in vitro cAMP assays, we performed a Mann–
Whitney U test. For IP3 assays, we performed
one-way ANOVA followed by aDunn’smultiple
post hoc test. For in vivo cAMP assays, prolifer-
ation, and nuclei quantification, we performed
one-way ANOVA followed by a Bonferroni
post hoc test. p values 0.05were considered to
be significant; specifically, *p  0.05; **p 
0.01; ***p 0.001.
Results
DhhCre;Gpr126fl/flmutant mice are viable
In an attempt to circumvent the lethality of constituitive Gpr126
mutantmice, we used conditionalmutantmice (Gpr126fl/fl). In the
mutant allele, exons 2 and 3 are replaced by a selection cassette
flanked by loxP sites (Fig. 1A,B). To verify the utility of this line,
we globally ablated Gpr126 by mating Gpr126fl/fl mice with mice
that express Cre recombinase under control of the -Actin (-
Act) promoter (Lewandoski et al., 1997). We observed the same
limb contracture defects (Fig. 1C) and early lethality in ActCre;
Gpr126fl/fl mutants as previously reported in constitutive
Gpr126/mutants (Monk et al., 2011). Additionally, we did not
detect Gpr126 mRNA in lung tissue from ActCre;Gpr126fl/fl
mutants (Fig. 1D), though it is normally highly expressed in this
tissue (Moriguchi et al., 2004; Haitina et al., 2008).
To begin to interrogate the function of Gpr126 in SCs, we
crossed Gpr126fl/fl mice with mice that express Cre recombinase
under control of the Desert hedgehog (Dhh) promoter, which
drives recombination in SC precursors at E12.5 (Jaegle et al.,
2003). Unlike constitutive Gpr126/ mutants, which showed
significant embryonic lethality (Monk et al., 2011), DhhCre;
Gpr126fl/fl animals were born in near-Mendelian ratios (53:315,
16.8%) and survived for 	1 year. Constitutive Gpr126/ mu-
tants were generally immotile (Monk et al., 2011); in contrast,
DhhCre;Gpr126fl/fl mutants were ambulatory, although they ex-
hibited trembling byP10. DhhCre;Gpr126fl/fl mutants were also
sometimes smaller than littermate controls, but this phenotype
was variable and not fully penetrant. We did not detect Gpr126
mRNA in sciatic nerve of DhhCre;Gpr126fl/fl mutants (Fig. 1E),
although Gpr126 was robustly expressed in the lungs of DhhCre;
Figure 1. DhhCre;Gpr126fl/fl mutant mice have nerve abnormalities. A, Schematic representations of mouse Gpr126 gene (top)
and protein (bottom). In the gene diagram, coding exons 1 and 23 and the targeted locus in Gpr126fl/fl mice (red arrows) are
denoted. The protein diagram depicts functional domains in Gpr126 protein: a Complement, Uegf, Bmp1 (CUB) domain, a Pen-
traxin (PTX) domain, a GPCR autoproteolysis-inducing domain that encompasses a GPCR proteolytic site (GPS) motif, and a type II
7TM domain. B, Targeting strategy used to generate Gpr126fl/fl mice. C,ActCre;Gpr126fl/fl (bottom left) andActCre;Gpr126fl/
sibling control (top right) mice at P1. Arrows indicate joint contracture defects. D, RT-PCR analysis of Gpr126 expression in cDNA
derived from P1 lung from animals of the indicated genotypes. Gpr126 is not detected inActCre;Gpr126fl/flmutant lung (n 2).
E, RT-PCR analysis of Gpr126 expression in cDNA derived from P14 sciatic nerves from animals of the indicated genotypes. Sox10,
but notGpr126, is detected in sciatic nerve fromDhhCre;Gpr126fl/flmice (n 3 animals, pooled). F–I, In situhybridization showing
Gpr126 expression in DRG (F,G) and sciatic nerve (H, I ). Gpr126 is expressed in DRG neurons (arrows) in control DhhCre;Gpr126fl/
mice (F ) andDhhCre;Gpr126fl/flmutantmice (G).Gpr126 is expressed in sciatic nerve SCs (arrowheads) in controlDhhCre;Gpr126fl/
mice (H ) but not in DhhCre;Gpr126fl/fl mutant mice (I ) at P21. For F–I, n 2 animals each genotype; scale bars, 20M.
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Gpr126fl/fl mutants (data not shown). Because most mRNAs in
the sciatic nerve are transcribed by SCs, this result suggests that
Gpr126 was efficiently recombined in DhhCre;Gpr126fl/fl mutant
SCs. To more thoroughly assess cell type-specific recombina-
tion efficiency of Gpr126 in DhhCre;
Gpr126fl/fl mutants, we performed in situ
hybridization on tissue sections from
DRGs and sciatic nerve from DhhCre;
Gpr126fl/fl and control DhhCre;Gpr126fl/
animals. We observed Gpr126 expression
in a pattern consistent with DRG neurons
in both control andDhhCre;Gpr126fl/flmu-
tants (Fig. 1F,G). We observed robust
Gpr126 expression in control nerve, in a
pattern consistent with SCs (Fig. 1H ). In
contrast, DhhCre;Gpr126fl/fl mutant sci-
atic nerve did not expressGpr126 (Fig. 1I)
and staining was indistinguishable from
sense controls (data not shown).
To further ensure that Gpr126 was ef-
ficiently recombined in SCs but not in
neurons, we examined LacZ expression
in DRG, spinal cord, and sciatic nerve of
DhhCre;Gpr126fl/;Rosa26R mice. We de-
tected robust LacZ expression in SCs of
the sciatic nerve at P15, but not in DRG
neurons or in the CNS (Fig. 2), which is
consistent with previous reports (Jaegle et
al., 2003; Wu et al., 2008). Importantly,
Gpr126fl/fl mice are healthy, fertile, and
show no obvious defects in SC develop-
ment or myelination (Fig. 3A,C; Fig. 4A; data not shown), indi-
cating that the neomycin selection cassette and LoxP sites
introduced at the Gpr126 locus (Fig. 1B) did not affect Gpr126
function. Further, we observed no difference in expression of
genes flankingGpr126 (Pex3,Aig1, andHivep2) in cDNA derived
from P4 sciatic nerve of Gpr126fl/fl or DhhCre;Gpr126fl/fl animals
compared with Gpr126fl/ by quantitative PCR (qPCR; data not
shown). Similarly, Gpr126 expression was not altered in cDNA
derived from P4 lung of Gpr126fl/fl or DhhCre;Gpr126fl/fl animals
compared withGpr126fl/ by qPCR (data not shown). Therefore,
Gpr126fl/fl mice represent a new tool with which to conditionally
ablate Gpr126 with cell-type specificity, and DhhCre;Gpr126fl/fl
mutants represent a useful model to examine the function of
Gpr126 in SCs.
DhhCre;Gpr126fl/flmutant mice show defects in radial sorting
andmyelination
Gross examination revealed thatDhhCre;Gpr126fl/flmutant sciatic
nerves were less opaque than control nerves at P21 (Fig. 3A,B),
indicative of reduced myelination. To test this, we examined sci-
atic nerve ultrastructure at multiple developmental stages be-
tween P1 and P42 by transmission electron microscopy (TEM).
Analysis of semithin sections stained by toluidine blue revealed a
lack ofmyelination inDhhCre;Gpr126fl/flmutants at P10, P21, and
P42 (Fig. 3D,F,H), and ultrastructural analyses revealedmultiple
defects in the mutants (Fig. 4). At P1, axons in control nerves
were well sorted; many axons were in a 1:1 relationship with SCs,
and occasional axons were surrounded by a thin myelin sheath
(Fig. 4A). In contrast, radial sorting was dramatically impaired in
sciatic nerves ofDhhCre;Gpr126fl/flmutants at P1. Mutant SC nu-
clei were observed at the edges of axon bundles (Fig. 4B) with very
little cytoplasmic interdigitation into the bundles (Fig. 4C). In-
terestingly, we did not observe perinatal axon degeneration in
DhhCre;Gpr126fl/fl mutant sciatic nerve, although this phenotype
was evident in constitutive Gpr126/ mutants (Monk et al.,
2011). Future analyses will determine whether Gpr126 has a neu-
Figure 2. DhhCre drives recombination in SCs but not neurons.A–F, Cross-sections of DRGs (A,B), ventral horn of spinal cord (C,
D), and sciatic nerve (E, F ) fromP15DhhCre;Gpr126fl/;Rosa26Rmice.-Galactosidase/LacZ stain (green) indicates a cell inwhich
Cre-mediated recombination has occurred. A, B, DRGs stained with LacZ (green), DAPI, and TUJ1 (A, red) or MBP (B, red) show no
expression of LacZ in sensory neuronal cell bodies.A’ andB’ show highermagnification of boxed region inA andB, respectively. C,
D, Ventral horn of the spinal cord stainedwith LacZ, DAPI, and TUJ1 (C) orMBP (D) showno expression of LacZ inmotor neuron cell
bodies or any other cell type in the spinal cord. C’, D’, Higher magnification of boxed region in C and D, respectively. E, F, Sciatic
nerve stainedwith LacZ, DAPI, and TUJ1 (E) or MBP (F ) show robust expression of LacZ in SCs (arrows). Scale bars: (in A, E) A,B, E,
F, 50m; (in C) C, D, 20m.
Figure3. DhhCre;Gpr126fl/flSCs fail togeneratemyelin.A,B, Sciatic nerves (arrows) fromP21
littermates. A, Control (Gpr126fl/fl shown) nerves are white and opaque. B, DhhCre;Gpr126fl/fl
nerves are translucent. C–H, Representative toluidine blue-stained semithin sections of sciatic
nerves from sibling control and DhhCre;Gpr126fl/fl mice. C, E, G, Many myelinated axons are
observed in control sciatic nerves at P10 (C, Gpr126fl/fl shown), P21 (E, DhhCre;Gpr126fl/
shown), and P42 (G, DhhCre;Gpr126fl/ shown). We did not observe differences between any
control genotype at any stage examined. Myelinated axons are not observed in DhhCre;
Gpr126fl/fl nerves at P10 (D), P21 (F ), or P42 (H ). Scale bar: (in C) C–H, 10 m. C–H, Black
arrows denote myelin sheaths, and white arrows denote SC nuclei.
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ronal function in survival/axonal mainte-
nance or whether neurons require a
Gpr126-mediated signal from SCs before
E12.5. In sum, this analysis suggests that
Gpr126 is required in SCs for timely radial
sorting.
At P21 and P42, large-caliber axons in
control nerves were well myelinated while
small-caliber axons were organized into
Remak bundles (Fig. 4D,G). In DhhCre;
Gpr126fl/fl mutant sciatic nerves at these
stages, many axons were sorted into a 1:1
relationship by SCs (Fig. 4E,H,J), al-
though nomyelinwas observed and radial
sorting defects persisted (Fig. 4E,F,H–
M). Furthermore, we observed aberrant
abaxonal cytoplasmic protrusions in
mutant SCs (Fig. 4F,I), similar to defects
previously reported in Rac1mutants (Ben-
ninger et al., 2007; Nodari et al., 2007; Guo
et al., 2012). These results suggest that
Gpr126 is required in SCs for myelination,
which is consistentwith chimeric analysis in
zebrafish mutants (Monk et al., 2009).
These results also suggest that Gpr126, like
Rac1, is required in SCs for membrane
stabilization.
DhhCre;Gpr126fl/flmutant SCs
are hyperproliferative
Examination of semithin sections stained
by toluidine blue suggested that more SC
nuclei were present in DhhCre;Gpr126fl/fl
mutant nerves compared with control
(Fig. 3). We assessed proliferation in P4
sciatic nerve by Ki67 immunostaining.
Proliferation was significantly increased
in DhhCre;Gpr126fl/fl mutant nerves com-
pared with control nerves (Fig. 5A–C),
and this increase in SC number persisted
at P21 (Fig. 5D). These data indicate that
loss of Gpr126 causes SCs to overprolifer-
ate and show that defects in radial sorting
and myelination are not due to a reduc-
tion in SC number.
cAMP elevation suppresses myelin
defects inGpr126mutants
For the majority of aGPCRs, downstream
signaling effectors are unknown or not
well defined. Moreover, although previ-
ous studies have supported a link between
aGPCRs and G-protein signaling (Lieb-
scher et al., 2013), direct G-protein cou-
pling has only been recently demonstrated for two family
members, GPR133 and GPR114 (Bohnekamp and Scho¨neberg,
2011; Gupte et al., 2012). We previously reported that forskolin
treatment to elevate cAMP suppresses myelin defects in gpr126
mutant zebrafish (Monk et al., 2009), suggesting that Gpr126
might couple toGs-protein and elevate cAMP. To begin to dissect
this signaling pathway, we first tested the hypothesis that cAMP
elevation would suppress myelin defects in Gpr126 mouse mu-
tants. To this end, we performedmyelinating assays in vitro using
DRGs derived from constitutive Gpr126/, Gpr126/, or
Gpr126/ animals with or without stimulation by compounds
that elevate cAMP.Myelin internodes, as assessed bymyelin basic
protein [MBP()] segments, were observed in Gpr126/ and
Gpr126/ (control) cultures after stimulation with ascorbic
acid to promote SC basal lamina formation andmyelination (El-
dridge et al., 1987; Fig. 6A,G). No differences were observed
between Gpr126/ and Gpr126/ cultures (data not shown).
MBP() internodes were never observed inGpr126/ cultures
Figure 4. DhhCre;Gpr126fl/fl SCs show multiple ultrastructural defects. A–C, TEMs from P1 animals. A, In control animals
(Gpr126fl/fl shown), thinmyelin is present around some axons (m), andmany axons are ensheathed by promyelinating SCs (p). B,
C, Radial sorting is significantlydelayed inDhhCre;Gpr126fl/flmutants.B, Lowmagnification showsSCnuclei (s) localized to theaxon
bundle edges, and very few axons are segregated by SCs. C, Higher magnification shows a SC nucleus on the periphery of many
naked axons.D–F, TEMs fromP21 animals.D, In control animals (DhhCre;Gpr126fl/ shown), axons are eitherwellmyelinated (m)
or ensheathed by Remak SC (R) cytoplasm. E, F, Myelin is absent and radial sorting delays persist in DhhCre;Gpr126fl/fl mutants. E,
Lowmagnification shows axons that have been sorted 1:1 by SCs (black asterisks), but remain unmyelinated. Bundles of unsorted
axons persist (white asterisks), and several of these axons are large caliber (	1m diameter). F, Higher magnification shows
aberrant cytoplasmic protrusions (arrowheads) inDhhCre;Gpr126fl/flmutant SCs.G–I, TEMs fromP42 animals.G, In control animals
(DhhCre;Gpr126fl/ shown), similar to P21, axons are well myelinated or ensheathed by Remak SCs. H, I, Nerve phenotypes
observed at P21 persist in DhhCre;Gpr126fl/fl mutants at P42. H, Low magnification shows that although more axons have been
sorted 1:1 by SCs (black asterisks), some large-caliber axons remain unsorted (white asterisks). In bundles of unsorted axons, some
axons remain in direct contact with each other and have no SC cytoplasmic interdigitations. I, Higher magnification shows
persistence of aberrant cytoplasmic protrusions (arrowheads). Scale bars: (in A) A, B, D, E,G,H, 500 nm; C, F, 1m; I, 2m. J–M,
Quantificationofaxonsand their relationshipswithSCs in the sciaticnervesofP21animals.Dataaregivenasmeans
SD.***p0.001.
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treated with ascorbic acid alone (Fig. 6B,G). Myelination was
potentiated in control cultures upon addition of 5 M forskolin
(Fig. 6C,G) to activate adenylyl cyclase and elevate cAMPor upon
addition of 250 M 8-(4-chlorophenylthio)-adenosine-3,5-
cAMP (8-CPT-cAMP; Fig. 6E,G), a cell-permeable cAMP analog
that activates PKA (Dostmann et al., 1990). In contrast to ascor-
bic acid alone, both forskolin and 8-CPT-cAMP stimulated
MBP() segment formation in Gpr126/ cultures (Fig.
6D,F,G). These data show that cAMP elevation suppresses
Gpr126/myelin defects inmammals.Moreover, since 8-CPT-
cAMP is a site-selective activator of PKA (Dostmann et al., 1990),
these results also support a model in which Gpr126 elevates
cAMP in SCs to activate PKA before myelination, which is con-
sistent with a recent report in zebrafish (Glenn andTalbot, 2013).
GPR126 elevates cAMP and couples to
heterotrimeric G-proteins
The ability of cAMP elevation to suppress mutant phenotypes in
Gpr126 zebrafish and mouse mutants suggested that Gpr126 ele-
vates cAMP. Since an agonist is not known for Gpr126, we took
advantage of the fact that GPCRs without bound agonists exist in
equilibriumbetween inactive and active conformations (Lefkow-
itz et al., 1993). Receptor overexpression does not change this
equilibrium but rather increases the number of receptors in both
conformations. At some point, a threshold is reached and the
active conformation can be detected due to constitutive activa-
tion of signaling pathways, which are normally activated after
agonist stimulation. The coupling ability of several receptors,
including “orphan” receptors, has been characterized by this
overexpression in the absence of an agonist (Eggerickx et al.,
1995; Schulz and Scho¨neberg, 2003; Preuss et al., 2007). We
transfected cDNA-encoding full-length
human GPR126 into COS-7 cells and
measured cAMP accumulation using a
second messenger assay. GPR126-
transfected COS-7 cells showed a
concentration-dependent increase of
cAMP levels (Fig. 7A). As a control, we
transfected human P2Y12, a known Gi-
coupling receptor (Yang et al., 2002). As
expected, P2Y12-transfected COS-7 cells
did not show a concentration-dependent
increase in cAMP, and cAMP accumula-
tion was significantly lower than in
GPR126-transfected cells (Fig. 7A).
Proper cell-surface expression of GPR126
was detected by ELISA (Fig. 7B). These
results show that full-length GPR126 can
localize to the plasma membrane and ele-
vate cAMP via the Gs/adenylyl cyclase
pathway in a concentration-dependent
manner.
To further define the G-protein-
coupling abilities of GPR126 to Gi-
proteins and Gq-proteins, we performed
IP3 accumulation assays. Transfection of
GPR126 into COS-7 cells alone did not
lead to an increase in IP3 levels, indicating
that this receptor does not couple to Gq
(Fig. 7C). Chimeric G-proteins, which
have the C-terminal 4 aa of a Gq-protein
exchanged for the corresponding amino
acids of Gs or Gi, can redirect the intra-
cellular signaling cascades of these respective GPCRs toward a
classicGq pathway, resulting in the production of IP3 as a down-
stream effector of PLC (Conklin et al., 1993). Using this well
established system, we cotransfected GPR126 and chimeric
G-proteins Gqi4 (to assess Gi coupling) or Gqs4 (to assess Gs
coupling). In both experiments, we observed a robust increase in
IP3 levels (Fig. 7C). Therefore, we conclude that GPR126 couples
to bothGi-proteins andGs-proteins, but notGq-proteins. Finally,
we measured cAMP concentration in DhhCre;Gpr126fl/fl mutant
sciatic nerve at P4 and found that cAMP levels in mutant nerves
were significantly reduced compared with control (Fig. 7D). To-
gether, these data show that GPR126 elevates cAMP and, like
many Gs-coupled GPCRs (Gudermann et al., 1997, Liebscher et
al., 2013), couples to Gi-proteins as well as Gs-proteins.
Discussion
Gpr126 couples to G-proteins and elevates cAMP
A role for cAMP in SC development and myelination has long
been hypothesized. Elegant studies spanning decades of work
have firmly established that axonal signals are required for SC
differentiation and myelination in vivo and in vitro (Wood and
Bunge, 1975; Weinberg and Spencer, 1978; Salzer and Bunge,
1980; Salzer et al., 1980a). In vitro, embryonic SCs grown in the
presence of neurons display a similar developmental progression as
SCs in vivo–theymigrate along neurites, proliferate, sort axons, and
myelinate axons (Wood,1976).Thesebehaviors relyon thepresence
of axons because in their absence, SCs fail to differentiate. The re-
quirement for neurons can be overcome in vitro by the addition of
axonal membrane fragments (Salzer et al., 1980a, 1980b) or by ele-
vating levels of cAMP in the SCs. Upon exogenous axonmembrane
application or cAMP elevation, SCs upregulate the expression of
Figure 5. DhhCre;Gpr126fl/fl SCs are hyperproliferative. A,B, Sciatic nerves stainedwith Ki67 (red) and DAPI (blue) in P4 control
(A; DhhCre;Gpr126fl/ shown) and DhhCre;Gpr126fl/fl mutants (B). C, Quantification of the percentage of Ki67() cells shows
significantly more proliferating cells in DhhCre;Gpr126fl/fl mutant nerve compared with control nerve at P4. D, Quantification of SC
number shows significantly more SCs DhhCre;Gpr126fl/fl in mutant nerve compared with control nerve at P21. Data are given as
means
 SD. *p 0.05; ***p 0.001.
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myelin-related molecules and downregulate the expression of im-
matureSCmarkers (Sobueet al., 1984;Mokunoet al., 1988;Monuki
et al., 1989; Mirsky et al., 1990; Morgan et al., 1991; Scherer et al.,
1994).Thus, an in vivo role for cAMPinSCmyelinationwashypoth-
esized; however, the identity of a receptor that might alter its levels
was only recently discovered.
Our previouswork in zebrafish offered the first piece of evidence
that cAMP elevation is essential for SC myelination in vivo. We
showed that treatment of gpr126mutant zebrafish larvae with fors-
kolin, an adenylyl cyclase activator that elevates cAMP, could sup-
pressmyelindefects in vivo (Monket al., 2009).This suggested, albeit
indirectly, thatGpr126 elevates cAMP.Here,we extend these studies
tomammals and show that addition of forskolin or 8-CPT-cAMP, a
cell-permeable cAMP analog that activates PKA, can suppress
Gpr126 mutant phenotypes in myelinating DRG cultures (Fig.
6D,F,G). These results are consistent with our previous studies in
zebrafish and support the notion that Gpr126 elevates cAMP. To
more definitively test this hypothesis, we show that GPR126 directly
elevates cAMP inCOS-7 cells (Fig. 7A), and thatGPR126 couples to
Gi-proteins and Gs-proteins (Fig. 7C). Together, our data support a
model in which Gpr126, via interactions with Gs, functions in SCs
to elevate cAMP and drive myelination. GPR126 also couples to
Gi-proteins, and although it is not uncommon forGPCRs to couple
tomore thanoneG-proteinclass (Gudermannetal., 1997;Liebscher
et al., 2013), this was not predicted from our rescue experiments. In
mouse SCs in vitro, low levels of cAMP promote neuregulin-
dependent proliferation, while high levels of cAMP promote differ-
entiation (Arthur-Farraj et al., 2011). Consistent with this model,
we observe overproliferation of SCs in cAMP-depleted DhhCre;
Gpr126fl/fl mutant sciatic nerve (Fig. 5). Via interactions with both
Gi-proteinsandGs-proteinsandvia integrationof signals fromother
essential pathways, Gpr126 could precisely regulate the concentra-
tion of cAMP required for a given stage of SC development.
Cellular autonomy of Gpr126
In zebrafish, we previously generated genetic chimeras in an at-
tempt to define the autonomy of Gpr126 inmyelination. In these
transplantation experiments, wild-type (WT) SCs in mutant
Figure 6. cAMP elevation rescues amyelination in Gpr126/mutants. A–F, In vitro DRGmyelinating cultures from Gpr126/ (control; A, C, E) and Gpr126/ embryos (B, D, F ) stained
with MBP (red), s100 (green), and DAPI (blue). A, Gpr126/ SCs myelinate axons after 2 weeks in culture following ascorbic acid addition (AA). This is potentiated by forskolin (FSK; C) or by
8-CPT-cAMP (E) addition.B,Gpr126/ SCs do notmyelinate axons following AA addition.MBP() segments are observed after addition of FSK (D) or 8-CPT-cAMP (F ). Scale Bar: (inA)A–F, 100
m. G, Quantification shows the number of MBP() segments observed in 1 mm2 in Gpr126/ (control) cocultures (gray bars) and in Gpr126/ cocultures (black bars). Data are given as
means
 SD of three independent experiments, each performed in triplicate. ***p 0.001.
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hosts were capable of expressing MBP,
even though they were associated with
gpr126mutant axons. This suggested that
Gpr126 functions in SCs for myelination.
However, MBP expression was also res-
cued when WT SCs and neurons were
present in mutant hosts, and importantly,
we did not perform TEM analyses to
determine whether WT SCs and neu-
rons together rescued myelination more
efficiently than SCs alone (Monk et al.,
2009). Furthermore, Gpr126 constitutive
mutant mice showed many defects that
were not observed in gpr126 mutant ze-
brafish, including perineurial-like cell
invasion throughout the endoneurium,
radial sorting delays, severe axon loss,
limb contracture defects, and lethality
(Monk et al., 2011). These observations
raised the question of whether Gpr126 has
essential functions in multiple cell types
during PNS development.
Our analysis of DhhCre;Gpr126fl/fl mu-
tants suggests that Gpr126 is required in
SCs for timely radial sorting and for my-
elination (Figs. 3, 4). We observed a lack
of myelination in DhhCre;Gpr126fl/fl mu-
tants at all ages examined up to P42 (Figs.
3, 4). We also observed severe delays in ra-
dial sorting in DhhCre;Gpr126fl/fl mutants at
all stages examined (Fig. 4). Interestingly,
we did not observe limb contracture de-
fects, perineurial-like cell invasion, axon
degeneration, or significant lethality in
DhhCre;Gpr126fl/fl mutants, though these
phenotypes were observed in constitutive
Gpr126 mutants. The lethality of constitu-
tive Gpr126 mutants is likely due to an es-
sential function for Gpr126 in heart
development (Waller-Evans et al., 2010; Pa-
tra et al., 2013). However, it is unclear
whether the other defects observed in con-
stitutive Gpr126 mutant PNS are due to a
Gpr126-dependent signal from SCs before
E12.5 or whether Gpr126might function in
other cells types in the developing nerve.
PreviousRT-PCRexperimentswere incon-
clusive regarding DRG expression of
Gpr126 (Monk et al., 2011), but our in situ
hybridization results demonstrate that
Gpr126 is expressed in a pattern consistent
with DRG neurons (Fig. 1F,G). Impor-
tantly, this expression was maintained in
DhhCre;Gpr126fl/fl mutants, although the
signal was less strong than in control nerve.
It is also important to note that DhhCre
drives recombination in endoneurial fibro-
blasts (Joseph et al., 2004), sowe cannot for-
mally exclude the possibility that Gpr126 is
also required in this cell type. Futurework is
needed to define the function(s) of Gpr126
in other cell types during peripheral nerve
development.
Figure 7. GPR126 directly elevates cAMP, couples to Gas and Gai, and cAMP is downregulated in DhhCre;Gpr126fl/fl mutant
nerves.A, COS-7 cells transfectedwith increasing amounts (100–600 ng/well) of plasmids encoding either humanGPR126 (black
circles) or human P2Y12 (white circles). After 2 d, intracellular cAMP levels were measured. cAMP concentration is shown as fold
change over empty vector (pcDps) control. GPR126, but not P2Y12, caused a dose-dependent increase of cAMP. Data are given as
means
 SDof four independent experiments, eachperformed in triplicate.B, COS-7 cellswere transfectedwith300ngof plasmid
encodinghumanGPR126 (blackbar), humanP2Y12 (graybar), or emptyvector (pcDps). After 2d, cell surfaceexpression levelswere
determined. OD values are given as the percentage of human P2Y12, which served as a positive control (percentage of positive
control). Data are given as means
 SD of three independent experiments, each performed in triplicate. C, To specify G-protein-
couplingabilities ofGPR126,weperformed IP3 accumulationassays,whichdetectGq-mediatedactivationofPLCand subsequent
increase in IP3. Through the use of chimeric Gqi4-proteins or Gqs4-proteins, Gi-coupling and Gs-coupling GPCRs can be
recognized and directed via the Gq-mediated pathway. For each assay, 1500 ng of GPR126 plasmid was cotransfected with 100
ng of either chimeric G-protein or empty vector. IP3 levels increased only with cotransfection of GPR126 with Gqi4 or Gqs4,
showing that GPR126 couples to both Gs-proteins and Gi-proteins, but not to Gq-proteins. Data are given as means
 SD of
three independent experiments, each performed in triplicate. D, cAMP is significantly downregulated in P4 DhhCre;Gpr126fl/fl
mutant nerve (black bar, n 3) comparedwith Gpr126fl/fl nerve (control, gray bar, n 5). Data are given asmeans
 SD. *p
0.05; **p 0.01; ***p 0.001.
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Phenotypic similarities betweenGpr126 and Rac1mutants
In addition to radial sorting delays and amyelination, we also
observed cytoplasmic protrusion defects in DhhCre;Gpr126fl/fl
mutants at P21 and P42 (Fig. 4F, I) strikingly similar to defects
previously reported in SC-conditional Rac1mutants (Benninger
et al., 2007; Nodari et al., 2007; Guo et al., 2012). The Rac1-like
defects were likely not observed in constitutive Gpr126 mutants
because these animals could not be examined past P12 due to
lethality. The phenotypic similarities between Gpr126 and Rac1
mutants suggest that these pathways interact. 1 Integrin is
known to activate Rac1 in SCs (Nodari et al., 2007), and deletion
of Itg1 or Rac1 in SCs leads to radial sorting delays similar to
those observed in Gpr126/ and DhhCre;Gpr126fl/fl mutants
(Feltri et al., 2002; Benninger et al., 2007; Nodari et al., 2007; Guo
et al., 2012). Gpr126 might indirectly activate Rac1, perhaps by
modulating 1 integrin, which would in turn activate Rac1.
Other aGPCRs have been shown to bind extracellular matrix
molecules via their N termini (Xu et al., 2006; Luo et al., 2011). It
is conceivable that the N terminus of Gpr126 binds components
of the basal lamina in SCs and that this could modulate 1 integ-
rin/laminin signaling. This is an attractive hypothesis to pursue in
future work, asGpr126mutant SCs also phenocopy radial sorting
defects observed in Lamininmutants (Chen and Strickland, 2003;
Yu et al., 2005). Gpr126 may thus indirectly modulate Rac1, and
Gpr126 may also directly activate Rac1. The -dimers of Gi-
coupled GPCRs are known to activate Rac1 via PI3K (Vogt et al.,
2007), and PKA also promotes Rac1 activation via stimulation of
Sif-like and Tiam1-like exchange factor (Goto et al., 2011).
In summary, our data support amodel in whichGpr126 func-
tions in SCs for timely radial sorting and myelination, and we
show that this aGPCR couples to Gi-proteins and Gs-proteins.
Via these G-protein interactions, Gpr126 can modulate precise
levels of cAMP required for different stages of SC development.
We hypothesize that both signals from Gpr126, cAMP/PKA ac-
tivity via Gs-proteins and -subunits release from Gi-proteins,
are essential for SC differentiation and myelination.
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